SCHEMBL8259308

SCHEMBL8259308

O=C(O)[C@@H]1C2CCC(CC2)N1C(=O)OCc1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AGTR2 P50052 6/20 0.56
SMN1; SMN2 Q16637 3/20 0.53
NPC1 O15118 3/20 0.53
RAB9A P51151 3/20 0.53
HTR2C P28335 1/20 0.52
CYP2C19 P33261 1/20 0.48
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
PSEN1 P49768 1/20 0.44
PSEN2 P49810 1/20 0.44
APH1B Q8WW43 1/20 0.44
NCSTN Q92542 1/20 0.44
APH1A Q96BI3 1/20 0.44
PSENEN Q9NZ42 1/20 0.44
PREP P48147 2/20 0.44
CACNA1G O43497 1/20 0.43
CACNA1H O95180 1/20 0.43
CACNA1I Q9P0X4 1/20 0.43
ALDH1A1 P00352 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7651346 1.00 AGTR2 (0.56) AGTR2SMN1; SMN2NPC1RAB9AHTR2C
SCHEMBL8350422 1.00 AGTR2 (0.56) AGTR2SMN1; SMN2NPC1RAB9AHTR2C
SCHEMBL8351858 0.92 AGTR2 (0.54) AGTR2SMN1; SMN2NPC1RAB9AHTR2C
SCHEMBL12798144 0.92 AGTR2 (0.54) AGTR2SMN1; SMN2NPC1RAB9AHTR2C
SCHEMBL7646821 0.92 AGTR2 (0.54) AGTR2SMN1; SMN2NPC1RAB9AHTR2C
SCHEMBL25125018 0.87 HTR2C (0.61) AGTR2SMN1; SMN2NPC1RAB9AHTR2C
SCHEMBL8260516 0.86 HTR2C (0.50) AGTR2SMN1; SMN2NPC1RAB9AHTR2C
SCHEMBL8795061 0.85 PREP (0.64) SMN1; SMN2NPC1RAB9ACYP2C19PREP
SCHEMBL16276273 0.83 HTR2C (0.49) AGTR2SMN1; SMN2NPC1RAB9AHTR2C
SCHEMBL14336080 0.82 HTR2C (0.57) AGTR2SMN1; SMN2NPC1RAB9AHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006096807-A1 AZA-BRIDGED-BICYCLIC AMINO ACID DERIVATIVES AS ALPHA 4 INTEGRIN ANTAGONISTS JANSSEN PHARMACEUTICA N.V. (BE) 2006-09-14 WO disclosed